Molecular strategies to define HLA haplotype loss in microdissected tumor cells

被引:60
作者
Ramal, LM
Maleno, I
Cabrera, T
Collado, A
Ferron, A
Lopez-Nevot, MA
Garrido, F
机构
[1] Dept Anal Clin, Granada, Spain
[2] Hosp Univ Virgen de las Nieves, Unidad Invest, Granada 18014, Spain
关键词
HLA; expression; tumor; LOH; beta(2)-microglobulin;
D O I
10.1016/S0198-8859(00)00171-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Loss of heterozygosity (LOH) of chromosome 6p21 is an important mechanism that generates HLA haplotype loss in various human tumors. This mechanism produces non-reversible HLA-deficient tumor cells char can escape T cell immune responses in peptide-vaccinated cancer patients. However, the exact frequency of this mechanism is still unknown, because contaminating stroma in solid tumor tissues masks the tumor DNA obtained from solid samples. A microdissection technique was applied to 4-8 mum sections of cryopreserved tumor tissues from a group of colorectal and laryngeal carcinomas. Fifteen patients were analyzed for the presence of LOH associated with the beta (2)-microglobulin gene in chromosome 15, and five patients for LOH associated with HLA genes in chromosome 6. In two cases, autologous metastasis tissue samples were also available. The patients were selected for showing an altered HLA class I tumor phenotype as determined by immunohistological techniques. DNA was obtained from this microdissected material and amplified in order to detect the presence or absence of nine previously selected microsatellite markers. HLA sequence based typing (SBT) was also applied to these microdissected DNA samples to define the HLA genotype. Microdissection greatly improved the definition of LOH, with nearly 100% signal reduction in one of the alleles, In addition, this procedure allowed us to detect beta (2)-microglobulin LOH in rumors that expressed some HLA molecules. Our data indicate that this procedure can be successfully applied to microdissected samples from solid rumors, thus enhancing the power and sensitivity of LOH detection. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:1001 / 1012
页数:12
相关论文
共 27 条
[1]   Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer [J].
Afonso, A ;
Emmert-Buck, MR ;
Duray, PH ;
Bostwick, DG ;
Lineman, WM ;
Vocke, CD .
JOURNAL OF UROLOGY, 1999, 162 (03) :922-926
[2]   A simple method for PCR based analyses of immunohistochemically stained, microdissected, formalin fixed, paraffin wax embedded material [J].
Alcock, HE ;
Stephenson, TJ ;
Royds, JA ;
Hammond, DW .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1999, 52 (03) :160-163
[3]   The HLA crossroad in tumor immunology [J].
Algarra, I ;
Cabrera, T ;
Garrido, F .
HUMAN IMMUNOLOGY, 2000, 61 (01) :65-73
[4]   Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides [J].
Benitez, R ;
Godelaine, D ;
Lopez-Nevot, MA ;
Brasseur, F ;
Jiménez, P ;
Marchand, M ;
Oliva, MR ;
van Baren, N ;
Cabrera, T ;
Andry, G ;
Landry, C ;
Ruiz-Cabello, F ;
Boon, T ;
Garrido, F .
TISSUE ANTIGENS, 1998, 52 (06) :520-529
[5]   High frequency of altered HLA class I phenotypes in invasive breast carcinomas [J].
Cabrera, T ;
Fernandez, MA ;
Sierra, A ;
Garrido, A ;
Herruzo, A ;
Escobedo, A ;
Fabra, A ;
Garrido, F .
HUMAN IMMUNOLOGY, 1996, 50 (02) :127-134
[6]   HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas [J].
Feenstra, M ;
Veltkamp, M ;
van Kuik, J ;
Wiertsema, S ;
Slootweg, P ;
van den Tweel, J ;
de Weger, R ;
Tilanus, M .
TISSUE ANTIGENS, 1999, 54 (03) :235-245
[7]   Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression [J].
Feenstra, M ;
Verdaasdonk, M ;
van der Zwan, AW ;
de Weger, R ;
Slootweg, P ;
Tilanus, M .
LABORATORY INVESTIGATION, 2000, 80 (03) :405-414
[8]   THE BIOLOGICAL CONSEQUENCES OF ALTERED MHC EXPRESSION ON TUMORS [J].
FESTENSTEIN, H .
BRITISH MEDICAL BULLETIN, 1987, 43 (01) :217-227
[9]   NATURAL-HISTORY OF HLA EXPRESSION DURING TUMOR-DEVELOPMENT [J].
GARRIDO, F ;
CABRERA, T ;
CONCHA, A ;
GLEW, S ;
RUIZCABELLO, F ;
STERN, PL .
IMMUNOLOGY TODAY, 1993, 14 (10) :491-499
[10]   Implications for immunosurveillance of altered HLA class I phenotypes in human tumours [J].
Garrido, F ;
RuizCabello, F ;
Cabrera, T ;
PerezVillar, JJ ;
LopezBotet, M ;
DugganKeen, M ;
Stern, PL .
IMMUNOLOGY TODAY, 1997, 18 (02) :89-95